Funds and ETFs Amgen Inc.

Equities

AMGN

US0311621009

Pharmaceuticals

Market Closed - Nasdaq 04:00:00 2024-05-24 pm EDT 5-day change 1st Jan Change
305.8 USD -0.22% Intraday chart for Amgen Inc. -2.12% +6.19%

ETFs positioned on Amgen Inc.

Name Weight AuM 1st Jan change Investor Rating
7.84% 0 M€ 0.00% -
7.63% 0 M€ 0.00% -
5.08% 116 M€ +15.87% -
3.71% 17 M€ +7.15% -
3.24% 1 M€ -0.95% -
2.61% 1 M€ +2.21% -
1.75% 4,592 M€ +11.18%
1.73% 9 M€ -4.31% -
1.67% 9 M€ -.--% -
1.65% 8 M€ +4.90%
1.55% 800 M€ +4.54%
1.37% 2 M€ +20.44% -
1.31% 5 M€ -72.95% -
1.29% 3 M€ 0.00% -
1.19% 15 M€ 0.00% -
1.04% 3,859 M€ +18.82% -
1.04% 469 M€ -2.05%
1.04% 1,100 M€ +4.58%
0.88% 2 M€ 0.00%
0.77% 265 M€ +6.05% -
0.75% 7 M€ +0.11% -
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8 USD
Average target price
316.3 USD
Spread / Average Target
+3.41%
Consensus
  1. Stock Market
  2. Equities
  3. AMGN Stock
  4. Funds and ETFs Amgen Inc.